N. Shabani

发表

Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.

R. Tiling, K. Hahn, H. Sommer, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

N. Harbeck, S. Braun, H. Sommer, 2004, Breast Cancer Research and Treatment.

Normal and Malignant Human Endometrium Express Immunohistochemically Estrogen Receptor Alpha ( ER-· ) , Estrogen Receptor Beta ( ER-‚ ) and Progesterone Receptor ( PR )

U. Jeschke, K. Friese, C. Kuhn, 2009 .

Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization.

I. Bauerfeind, U. Jeschke, K. Friese, 2006, Fertility and sterility.

Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium.

U. Jeschke, K. Friese, C. Kuhn, 2004, Acta histochemica.

Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary

U. Jeschke, K. Friese, A. Burges, 2010, Archives of Gynecology and Obstetrics.

Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.

A. Brüning, I. Mylonas, T. Blankenstein, 2010, Oncology reports.

Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.

U. Jeschke, K. Friese, R. Speer, 2005, Anticancer research.

Steroid receptors ER α , ERß , PRA and PRB are differentially expressed in normal and atrophic human endometrium

U. Jeschke, K. Friese, C. Kuhn, 2006 .

The Human Endometrium Expresses the Glycoprotein Mucin-1 and Shows Positive Correlation for Thomsen-Friedenreich Epitope Expression and Galectin-1 Binding

U. Jeschke, K. Friese, C. Kuhn, 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle

U. Jeschke, K. Friese, C. Kuhn, 2000, Histochemistry and Cell Biology.

Expression of Estrogen Receptors · and ‚ , and Progesterone Receptors A and B in Human Mucinous Carcinoma of the Endometrium

U. Jeschke, K. Friese, C. Kuhn, 2008 .

Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium.

U. Jeschke, K. Friese, C. Kuhn, 2007, Histology and histopathology.

Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Expression of the inhibin/activin subunits (-α, -βA and -βB) in normal and carcinogenic endometrial tissue: Possible immunohistochemical differentiation markers

U. Jeschke, K. Friese, C. Kuhn, 2007 .

Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines

A. Brüning, I. Mylonas, D. Dian, 2009, Journal of Molecular Histology.

Correction: Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue

M. Kupka, I. Mylonas, N. Shabani, 2011, Reproductive Biology and Endocrinology : RB&E.

Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.

U. Jeschke, K. Friese, C. Kuhn, 2007, Oncology reports.

Inhibin/activin subunits (inhibin-α, -βA and -βB) are differentially expressed in human breast cancer and their metastasis

U. Jeschke, K. Friese, C. Kuhn, 2005 .

Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.

U. Jeschke, K. Friese, C. Kuhn, 2005, Oncology reports.

Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Expression of inhibin/activin subunits, sialyl-lewis A (CA 19-9, sLea) and sialyl-Lewis X (sLex) carbohydrate antigens in a hydatidiform mole with persistent polymorphic trophoblastic hyperplasia.

U. Jeschke, K. Friese, M. Vogel, 2005, Anticancer research.

Invasive hydatidiform mole: immunohistochemical labelling of inhibin/activin subunits, Ki67, p53 and glycodelin A in a rare case.

K. Friese, B. Gerber, I. Mylonas, 2009, Acta histochemica.

The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Evaluation of two commercialised in situ hybridisation assays for detecting HPV-DNA in formalin-fixed, paraffin-embedded tissue

A. Brüning, I. Mylonas, T. Blankenstein, 2011, Archives of Gynecology and Obstetrics.

Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line

A. Burges, A. Brüning, I. Mylonas, 2011, Archives of Gynecology and Obstetrics.

Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.

H. Sommer, U. Jeschke, K. Friese, 2009, European Journal of Cancer.

Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.

U. Jeschke, K. Friese, W. Janni, 2005, Anticancer research.

Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.

H. Sommer, U. Jeschke, K. Friese, 2007, European journal of cancer.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?

S. Braun, H. Sommer, K. Friese, 2005, Journal of Cancer Research and Clinical Oncology.

Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer

K. Friese, C. Kuhn, A. Brüning, 2011, Archives of Gynecology and Obstetrics.

Expression of cathepsin-D in primary breast cancer and corresponding local recurrence or metastasis: an immunohistochemical study.

U. Jeschke, K. Friese, C. Kuhn, 2012, Anticancer research.

Expression of HPV, Steroid Receptors (ERα, ERβ, PR-A and PR-B) and Inhibin/Activin Subunits (α, βA and βB) in Adenosquamous Endometrial Carcinoma

U. Jeschke, K. Friese, C. Kuhn, 2007 .

Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.

U. Jeschke, K. Friese, B. Gerber, 2005, Anticancer research.

Immunolabeling of the Inhibin-&bgr;A and -&bgr;B Subunit in Normal and Malignant Human Cervical Tissue and Cervical Cancer Cell Lines

A. Brüning, I. Mylonas, T. Blankenstein, 2010, International Journal of Gynecologic Cancer.

Prognostic significance of oestrogen receptor alpha (ERα) and beta (ERβ), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas

H. Sommer, U. Jeschke, K. Friese, 2007 .

Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.

Ioannis Mylonas, Doris Mayr, U. Jeschke, 2007, Anticancer research.

The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERβ, and enhances expression of oncogenic cytokine GRO

U. Jeschke, K. Friese, A. Brüning, 2008, Cancer biology & therapy.

Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.

U. Jeschke, K. Friese, W. Janni, 2005, Oncology reports.

Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.

U. Jeschke, K. Friese, I. Mylonas, 2005, Anticancer research.

Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue

M. Kupka, A. Brüning, I. Mylonas, 2010, Reproductive biology and endocrinology : RB&E.

Development and characterisation of an antibody for the immunohistochemical detection of inhibin/activin betaE (betaE) in normal human ovarian and placental tissue.

U. Jeschke, K. Friese, C. Kuhn, 2009, Acta histochemica.

Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).

U. Jeschke, K. Friese, C. Kuhn, 2005, Anticancer research.

Immunohistochemical visualisation of cathepsin-D expression in breast cancer.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer Research.

Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.

Volker Briese, Ioannis Mylonas, U. Jeschke, 2005, European journal of obstetrics, gynecology, and reproductive biology.

Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue

M. Kupka, I. Mylonas, N. Shabani, 2010, Reproductive biology and endocrinology : RB&E.